BACKGROUND: Common polymorphisms of the fat mass and obesity associated gene (FTO) have been linked to obesity in some populations. One of these genetic variants (rs9939609) has been related to an increased risk of obesity. OBJECTIVE: Our aim was to evaluate weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with RS9939609 gene variant. DESIGN:305 obese patients were enrolled in a prospective way. In the basal visit, patients were randomly allocated during 3 months to low carbohydrates and low fat. RESULTS: After treatment with both diets and in both genotypes, weight, fat mass, waist circumference and systolic blood pressures decreased. With the diet type I and in TT genotype, insulin (-6.6 ± 9.8 IU/L) and homeostasis model assessment (-2.9 ± 6.1 units) decreased. With the diet type II and in both genotypes (wild and mutant type), insulin (-5.2 ± 6.1 vs. -3.8 ± 6.1 IU/L; p < 0.05) and homeostasis model assessment (-2.4 ± 4.8 vs. -1.1 ± 3.8 kg; p < 0.05) decreased. In the A allele group, a significant decrease was detected in total cholesterol levels (-11.5 ± 20.1 mg/dL), low density lipoprotein cholesterol levels (-13.2 ± 20.9 mg/dL) and c-reactive protein levels (-1.3 ± 3.8 mg/dL) secondary to weight loss after treatment with diet II. The decrease of leptin levels was higher in mutant type group than wild type group with low fat diet (-10.3 ± 36.1 vs. -28.6 ± 53.7 ng/mL; p < 0.05). CONCLUSION: Metabolic improvement secondary to weight loss was better in A carriers with a low fat hypocaloric diet.
RCT Entities:
BACKGROUND: Common polymorphisms of the fat mass and obesity associated gene (FTO) have been linked to obesity in some populations. One of these genetic variants (rs9939609) has been related to an increased risk of obesity. OBJECTIVE: Our aim was to evaluate weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with RS9939609 gene variant. DESIGN: 305 obesepatients were enrolled in a prospective way. In the basal visit, patients were randomly allocated during 3 months to low carbohydrates and low fat. RESULTS: After treatment with both diets and in both genotypes, weight, fat mass, waist circumference and systolic blood pressures decreased. With the diet type I and in TT genotype, insulin (-6.6 ± 9.8 IU/L) and homeostasis model assessment (-2.9 ± 6.1 units) decreased. With the diet type II and in both genotypes (wild and mutant type), insulin (-5.2 ± 6.1 vs. -3.8 ± 6.1 IU/L; p < 0.05) and homeostasis model assessment (-2.4 ± 4.8 vs. -1.1 ± 3.8 kg; p < 0.05) decreased. In the A allele group, a significant decrease was detected in total cholesterol levels (-11.5 ± 20.1 mg/dL), low density lipoprotein cholesterol levels (-13.2 ± 20.9 mg/dL) and c-reactive protein levels (-1.3 ± 3.8 mg/dL) secondary to weight loss after treatment with diet II. The decrease of leptin levels was higher in mutant type group than wild type group with low fat diet (-10.3 ± 36.1 vs. -28.6 ± 53.7 ng/mL; p < 0.05). CONCLUSION: Metabolic improvement secondary to weight loss was better in A carriers with a low fat hypocaloric diet.
Authors: James L Dorling; Daniel W Belsky; Susan B Racette; Sai Krupa Das; Eric Ravussin; Leanne M Redman; Christoph Höchsmann; Kim M Huffman; William E Kraus; Michael S Kobor; Julia L MacIsaac; David T S Lin; David L Corcoran; Corby K Martin Journal: Exp Gerontol Date: 2021-09-20 Impact factor: 4.032
Authors: Katherine M Livingstone; Carlos Celis-Morales; George D Papandonatos; Bahar Erar; Jose C Florez; Kathleen A Jablonski; Cristina Razquin; Amelia Marti; Yoriko Heianza; Tao Huang; Frank M Sacks; Mathilde Svendstrup; Xuemei Sui; Timothy S Church; Tiina Jääskeläinen; Jaana Lindström; Jaakko Tuomilehto; Matti Uusitupa; Tuomo Rankinen; Wim H M Saris; Torben Hansen; Oluf Pedersen; Arne Astrup; Thorkild I A Sørensen; Lu Qi; George A Bray; Miguel A Martinez-Gonzalez; J Alfredo Martinez; Paul W Franks; Jeanne M McCaffery; Jose Lara; John C Mathers Journal: BMJ Date: 2016-09-20